320 related articles for article (PubMed ID: 33392895)
21. [Vogt-Koyanagi-Harada syndrome in the setting of vemurafenib therapy for metastatic melanoma: a case report].
Ren XT; Guo T; Yang F; Wu WY; Dou HL; Li XM
Zhonghua Yan Ke Za Zhi; 2022 Nov; 58(11):925-928. PubMed ID: 36348532
[TBL] [Abstract][Full Text] [Related]
22. Development of Vogt-Koyanagi-Harada disease-like uveitis during treatment by anti-programmed death-1 antibody: a case report.
Wang JN; Zhang Y; Huang CY; Li K; Yu XB
BMC Ophthalmol; 2024 Jun; 24(1):240. PubMed ID: 38849786
[TBL] [Abstract][Full Text] [Related]
23. Intravitreal triamcinolone acetonide in Vogt-Koyanagi-Harada syndrome.
Karacorlu M; Arf Karacorlu S; Ozdemir H
Eur J Ophthalmol; 2006; 16(3):481-3. PubMed ID: 16761256
[TBL] [Abstract][Full Text] [Related]
24. The contribution of indocyanine green angiography to the appraisal and management of Vogt-Koyanagi-Harada disease.
Bouchenaki N; Herbort CP
Ophthalmology; 2001 Jan; 108(1):54-64. PubMed ID: 11150265
[TBL] [Abstract][Full Text] [Related]
25. [Vogt-Koyanagi-Harada disease].
Kjeka O; Krohn J
Tidsskr Nor Laegeforen; 2005 Aug; 125(16):2195-7. PubMed ID: 16138134
[TBL] [Abstract][Full Text] [Related]
26. Vogt-Koyanagi-Harada syndrome. A case report.
Iversen TH; Sverrisson T
Acta Ophthalmol (Copenh); 1986 Apr; 64(2):235-8. PubMed ID: 3727967
[TBL] [Abstract][Full Text] [Related]
27. Retinal vessel oxygen saturation is affected in uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; AlBloushi AF; Gikandi PW; Hardarson SH; Stefánsson E
Br J Ophthalmol; 2019 Dec; 103(12):1695-1699. PubMed ID: 30798260
[TBL] [Abstract][Full Text] [Related]
28. Annular choroidal detachment in a patient with Vogt-Koyanagi-Harada disease.
Yamamoto N; Naito K
Graefes Arch Clin Exp Ophthalmol; 2004 Apr; 242(4):355-8. PubMed ID: 14963715
[TBL] [Abstract][Full Text] [Related]
29. Indocyanine green angiography in Vogt-Koyanagi-Harada disease: angiographic signs and utility in patient follow-up.
Herbort CP; Mantovani A; Bouchenaki N
Int Ophthalmol; 2007; 27(2-3):173-82. PubMed ID: 17457515
[TBL] [Abstract][Full Text] [Related]
30. Indocyanine green angiographic findings in Vogt-Koyanagi-Harada disease.
Oshima Y; Harino S; Hara Y; Tano Y
Am J Ophthalmol; 1996 Jul; 122(1):58-66. PubMed ID: 8659599
[TBL] [Abstract][Full Text] [Related]
31. Multimodal Imaging Approach in a Patient with Vogt-Koyanagi-Harada-like Syndrome Due to Dabrafenib and Trametinib Use for Cutaneous Melanoma.
Bellanca RF; Pinna A; Catania G; Belcastro E; Angi M; D'Amico Ricci G
Ocul Immunol Inflamm; 2023 Feb; 31(2):402-406. PubMed ID: 35113757
[TBL] [Abstract][Full Text] [Related]
32. Unilateral Ocular Manifestations of Vogt-Koyanagi-Harada Disease.
Tsui E; Bottini A; Ghadiali Q; Balaratnasingam C; Barbazetto I
Ocul Immunol Inflamm; 2018; 26(8):1297-1300. PubMed ID: 29020488
[TBL] [Abstract][Full Text] [Related]
33. Concomitant choroidal inflammation during anterior segment recurrence in Vogt-Koyanagi-Harada disease.
Bacsal K; Wen DS; Chee SP
Am J Ophthalmol; 2008 Mar; 145(3):480-486. PubMed ID: 18191100
[TBL] [Abstract][Full Text] [Related]
34. Vogt-Koyanagi-Harada syndrome (uveomeningoencephalitic syndrome).
Manethova K; Ernest J; Hrevus M
Eur J Ophthalmol; 2017 Jan; 27(1):e5-e8. PubMed ID: 28009404
[TBL] [Abstract][Full Text] [Related]
35. Development of Vogt-Koyanagi-Harada Disease-like Uveitis during Treatment by Anti-programmed Death Ligand-1 Antibody for Non-small Cell Lung Cancer: A Case Report.
Suwa S; Tomita R; Kataoka K; Ueno S
Ocul Immunol Inflamm; 2022 Aug; 30(6):1522-1526. PubMed ID: 33797309
[TBL] [Abstract][Full Text] [Related]
36. Full-field electroretinogram behavior in Vogt-Koyanagi-Harada disease: a 24-month longitudinal study in patients from acute onset evaluated with multimodal analysis.
Sakata VM; Lavezzo MM; da Silva FT; Rodriguez EEC; Morita C; Abdallah SF; Oyamada MK; Hirata CE; Yamamoto JH
Graefes Arch Clin Exp Ophthalmol; 2019 Oct; 257(10):2285-2295. PubMed ID: 31440820
[TBL] [Abstract][Full Text] [Related]
37. PREDICTIVE ROLE OF SWEPT SOURCE OCT ANGIOGRAPHY IN RELAPSING VOGT-KOYANAGI-HARADA DISEASE.
Interlandi E; Pellegrini F; Papayannis A; Latanza L; Pece A; Pavesio C
Retin Cases Brief Rep; 2023 Jul; 17(4):414-418. PubMed ID: 35880955
[TBL] [Abstract][Full Text] [Related]
38. Vogt-Koyanagi-Harada disease.
O'Keefe GA; Rao NA
Surv Ophthalmol; 2017; 62(1):1-25. PubMed ID: 27241814
[TBL] [Abstract][Full Text] [Related]
39. [Bilateral Nivolumab-associated Vogt-Koyanagi-Harada-like Uveitis in a Patient with Metastatic Renal Cell Carcinoma].
Czichos C; Wawrzynów B; Chamalis C; von Jagow B
Klin Monbl Augenheilkd; 2021 Jun; 238(6):711-714. PubMed ID: 33395707
[No Abstract] [Full Text] [Related]
40. RETINAL PIGMENT EPITHELIUM UNDULATIONS IN ACUTE STAGE OF VOGT-KOYANAGI-HARADA DISEASE: Biomarker for Functional Outcomes After High-Dose Steroid Therapy.
Hashizume K; Imamura Y; Fujiwara T; Machida S; Ishida M; Kurosaka D
Retina; 2016 Feb; 36(2):415-21. PubMed ID: 26352553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
